159 related articles for article (PubMed ID: 16926677)
1. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
[TBL] [Abstract][Full Text] [Related]
2. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
3. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.
Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
J Am Coll Cardiol; 1999 Oct; 34(4):1176-83. PubMed ID: 10520809
[TBL] [Abstract][Full Text] [Related]
8. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.
Viitanen L; Pihlajamäki J; Halonen P; Lehtonen M; Kareinen A; Lehto S; Laakso M
Atherosclerosis; 2001 Jul; 157(1):57-64. PubMed ID: 11427204
[TBL] [Abstract][Full Text] [Related]
9. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
Velickovic J; Jelicic M; Stojkovic O
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
[TBL] [Abstract][Full Text] [Related]
10. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
Wong TY; Poon P; Szeto CC; Chan JC; Li PK
Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
Sun L; Lv H; Wei W; Zhang D; Guan Y
J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
Aarabi M; Memariani T; Arefi S; Aarabi M; Hantoosh Zadeh S; Akhondi MA; Modarressi MH
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):545-8. PubMed ID: 20822334
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
[TBL] [Abstract][Full Text] [Related]
14. [The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].
Kaya H; Karkucak M; Salifoğlu H; Torun D; Kozan S; Tunca Y
Tuberk Toraks; 2013; 61(2):88-95. PubMed ID: 23875585
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study.
Pankow JS; Arnett DK; Borecki IB; Hunt SC; Eckfeldt JH; Folsom AR; Djoussé L
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):551-8. PubMed ID: 10997795
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusion.
Mattes D; Weger M; Renner W; Cichocki L; Haas A
J Thromb Haemost; 2005 Nov; 3(11):2583-4. PubMed ID: 16241960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
